Literature DB >> 16813620

Questionnaire to aid priority and outcomes assessment in gallstone disease.

Tina Y T Chen1, Michael G Landmann, Jonathan C Potter, Andre M van Rij.   

Abstract

BACKGROUND: Limited health resources necessitate prioritization for access to elective cholecystectomy in New Zealand. We aimed to develop and validate a patient questionnaire for determining the effect of gallstone disease on quality of life (QOL) and evaluate its potential role in appraising prioritization and outcomes from surgery.
METHODS: The Otago gallstones condition-specific questionnaire (CSQ) was designed based on review of published reports, structural equation modelling, input from experts and patient feedback. Fifty-four patients with symptomatic gallstone disease completed the CSQ including a single question asking about global condition impact, along with other QOL measures: the Gallstone Impact Checklist and the Short Form-36 Health Survey. Validity and reliability of the CSQ were assessed using standard psychometric criteria and patient acceptance was explored in a semistructured interview. Patients' priority status for surgery was determined by two participating surgeons and resulting scores were correlated with the QOL measures.
RESULTS: Average CSQ completion time was 2.7 (range 1-5) min and patients found its content concise and comprehensive. Validity was supported through high correlations with the Gallstone Impact Checklist (r = 0.74), the global condition impact (r = 0.69) and related dimensions of the Short Form-36 Health Survey. CSQ questions showed satisfactory internal consistency (Cronbach's alpha = 0.94) and reproducibility (ICC = 0.93, where ICC is intraclass coefficient). Of all the QOL measures, the CSQ was the most clinically relevant, showing the strongest relationship with surgeon-rated priority (r = 0.62).
CONCLUSION: Evidence is provided to support the validity of the CSQ for assessing the effect of gallstone disease on QOL. The CSQ could be particularly valuable in aiding priority decisions surgeons make and may be useful in tracking subsequent outcomes.

Entities:  

Mesh:

Year:  2006        PMID: 16813620     DOI: 10.1111/j.1445-2197.2006.03777.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  6 in total

1.  Measurement of patient-reported outcomes after laparoscopic cholecystectomy: a systematic review.

Authors:  Harry C Alexander; Cindy H Nguyen; Matthew R Moore; Adam S Bartlett; Jacqueline A Hannam; Garth H Poole; Alan F Merry
Journal:  Surg Endosc       Date:  2019-04-01       Impact factor: 4.584

Review 2.  A systematic review of patient reported outcome measures (PROMs) and quality of life reporting in patients undergoing laparoscopic cholecystectomy.

Authors:  Prita Daliya; Elizabeth H Gemmill; Dileep N Lobo; Simon L Parsons
Journal:  Hepatobiliary Surg Nutr       Date:  2019-06       Impact factor: 7.293

3.  Patient reporting of complications after surgery: what impact does documenting postoperative problems from the perspective of the patient using telephone interview and postal questionnaires have on the identification of complications after surgery?

Authors:  John Woodfield; Priya Deo; Ann Davidson; Tina Yen-Ting Chen; Andre van Rij
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

4.  Erythromelalgia? A clinical study of people who experience red, hot, painful feet in the community.

Authors:  D Friberg; T Chen; G Tarr; A van Rij
Journal:  Int J Vasc Med       Date:  2013-05-15

5.  The Influence of Clinical and Patient-Reported Outcomes on Post-surgery Satisfaction in Cholecystectomy Patients.

Authors:  K A McLean; Z Sheng; S O'Neill; K Boyce; C Jones; S J Wigmore; E M Harrison
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

6.  Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set.

Authors:  Moira Cruickshank; Rumana Newlands; Jane Blazeby; Irfan Ahmed; Mohamed Bekheit; Miriam Brazzelli; Bernard Croal; Karen Innes; Craig Ramsay; Katie Gillies
Journal:  BMJ Open       Date:  2021-06-24       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.